Zoetis Ownership
| ZOE Stock | EUR 147.00 3.12 2.08% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Zoetis |
Zoetis Stock Ownership Analysis
About 94.0% of the company outstanding shares are owned by institutional investors. The company last dividend was issued on the 20th of April 2023. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. ZOETIS INC operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10000 people. For more information please call the company at 973 822 7000 or visit https://www.zoetis.com.Zoetis Outstanding Bonds
Zoetis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zoetis Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zoetis bonds can be classified according to their maturity, which is the date when Zoetis Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US98971DAB64 Corp BondUS98971DAB64 | View | |
| ZOETIS INC 395 Corp BondUS98978VAM54 | View | |
| ZOETIS INC 39 Corp BondUS98978VAN38 | View | |
| ZOETIS INC 45 Corp BondUS98978VAK98 | View | |
| ZOETIS INC 3 Corp BondUS98978VAL71 | View | |
| ZOETIS INC Corp BondUS98978VAS25 | View | |
| ZOETIS INC 445 Corp BondUS98978VAP85 | View | |
| ZTS 56 16 NOV 32 Corp BondUS98978VAV53 | View |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zoetis Stock
When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.